Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease dermatomyositis
Phenotype C0206062|interstitial lung disease
Sentences 27
PubMedID- 26101728 Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study.
PubMedID- 22781896 [a clinical analysis of dermatomyositis with interstitial lung disease in 20 patients].
PubMedID- 23250474 Autoantibodies against melanoma differentiation-associated gene 5 (mda5) are important serological markers in dermatomyositis (dm) with rapidly progressive interstitial lung disease (ild).
PubMedID- 20506189 Conclusion: these promising data indicate that mycophenolate mofetil may be a useful therapy for interstitial lung disease in patients with dermatomyositis, but larger studies are needed to more definitively evaluate the role of this medication in therapy.
PubMedID- 24252021 Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease.
PubMedID- 25433590 [interstitial lung disease-associated with amyopathic dermatomyositis and anti-mda5 autoantibodies].
PubMedID- 25698373 A case of anti-mda5-positive rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis ameliorated by rituximab, in addition to standard immunosuppressive treatment.
PubMedID- 23158422 Objective: to explore the possible diagnostic values of serum surfactant protein-a (sp-a) and surfactant protein-d (sp-d) for interstitial lung diseases (ild) in patients with polymyositis or dermatomyositis (pm/dm).
PubMedID- 26459323 The objective of this study is to assess serum il8 and the potential activity of circulating neutrophils on relative messenger rna (mrna) levels and their relationship with disease activity in clinically amyopathic dermatomyositis (cadm) associated with interstitial lung disease (ild).
PubMedID- 22931947 Objective: to explore the clinical and laboratory features and the prognosis of juvenile dermatomyositis (jdm) complicated with interstitial lung disease (ild).
PubMedID- 22325787 Clinical factors to predict a poor prognosis and refractory disease in patients with polymyositis and dermatomyositis associated with interstitial lung disease.
PubMedID- 25622670 Objective: to explore the clinical features and prognosis of dermatomyositis patients with interstitial lung disease (ild) as an initial manifestation.
PubMedID- 23983712 He was suspected of rapidly progressing interstitial lung disease with dermatomyositis and transferred to our hospital.
PubMedID- 21532064 Anti-cadm-140 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and cardiac involvement.
PubMedID- 20800454 Serum tarc/ccl17 levels are increased in dermatomyositis associated with interstitial lung disease.
PubMedID- 23569020 Objective: : to study the clinical features of interstitial lung disease (ild) in patients with dermatomyositis and factors related to its development.
PubMedID- 25888887 Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis.
PubMedID- 23400027 Limitations to the 6-minute walk test in dermatomyositis with interstitial lung disease in comparison with idiopathic interstitial pneumonia.
PubMedID- 26328651 Rapidly progressive interstitial lung disease associated with dermatomyositis treated with combination of immunosuppressive therapy, direct hemoperfusion with a polymyxin b immobilized fiber column and intravenous immunoglobulin.
PubMedID- 22460910 Early diagnosis and treatment for remission of clinically amyopathic dermatomyositis complicated by rapid progress interstitial lung disease: a report of two cases.
PubMedID- 23423441 This diagnosis should always come to mind in patients that present with signs of myositis, dermatomyositis, or polymyositis associated with interstitial lung disease.
PubMedID- 24325117 Objective: to investigate the clinical features and risk factors associated with interstitial lung disease (ild) in patients with classic dermatomyositis (classic dm) or clinical amyopathic dermatomyositis (cadm).
PubMedID- 24142786 [interstitial lung disease in patients with polymyositis and dermatomyositis--report of three cases].
PubMedID- 25346167 Anti-transcription intermediary factor 1-gamma antibody-positive clinically amyopathic dermatomyositis complicated by interstitial lung disease and breast cancer.
PubMedID- 21748914 Subsequently, a diagnosis of amyopathic dermatomyositis with interstitial lung disease and pneumomediastinum was made.
PubMedID- 25431723 At the initial visit, clinically amyopathic dermatomyositis (cadm) with rapidly progressive interstitial lung disease (rp-ild) was suspected because he had progressive dyspnea but no muscle weakness.
PubMedID- 22863719 Pilot study of interleukin-27 in pathogenesis of dermatomyositis and polymyositis: associated with interstitial lung diseases.

Page: 1